The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

XOMA Corp

Nasdaq: XOMA
Last

(U.S.) $0.55

Today's change0.00 0.00%
Updated June 30 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

XOMA Corp

Nasdaq: XOMA
Last

(U.S.) $0.55

Today's change0.00 0.00%
Updated June 30 4:00 PM -4GMT. Delayed by at least 15 minutes.

XOMA Corp closed at (U.S.)$0.55.

Over the last five days, shares have lost 2.75% and are down 58.55% for the last year to date. This security has underperformed the S&P 500 by 87.52% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $0.55
  • High--
  • Low--
  • Bid / Ask(U.S.) $0.42 / (U.S.) $0.65
  • YTD % change-58.55%
  • Volume0
  • Average volume (10-day)2,533,270
  • Average volume (1-month)1,339,207
  • Average volume (3-month)1,388,599
  • 52-week range(U.S.) $0.44 to (U.S.) $4.93
  • Beta2.71
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.06
Updated June 30 4:00 PM -4GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-12.78%

Although this company's net profit margin is negative, it is above the industry average and implies that XOMA Corp is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.20%Sector:HealthcareIndustry:Biotechnology

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue44823
Total other revenue--------
Total revenue44823
Gross profit--------
Total cost of revenue--------
Total operating expense18192625
Selling / general / administrative4565
Research & development14141820
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0130
Other operating expenses, total--------
Operating income-1429-24-22
Interest income (expense), net non-operating-1-1-1-1
Gain (loss) on sale of assets--------
Other--------
Income before tax-8250-24
Income after tax-8250-24
Income tax, total--------
Net income-8250-24
Total adjustments to net income--------
Net income before extra. items-8250-24
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-8250-24
Inc. avail. to common incl. extra. items-8250-24
Diluted net income-8250-24
Dilution adjustment--------
Diluted weighted average shares120119119118
Diluted EPS excluding extraordinary itemsvalue per share-0.070.210.00-0.20
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.070.220.02-0.20